ArticleBMC bioinformatics2026
MODCAN: driver gene identification based on multi-omics features and differential co-association networks for tumor subtypes.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disentangling Heterogeneous Molecular Networks for Multi-Omics-Driven Cancer Driver Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDespite the identification of some pan-cancer driver genes through international collaborative initiatives, the discovery of key cancer driver genes remains a formidable challenge. This limitation continues to hinder progress in critical areas, such as early diagnosis, prognostic evaluation, and precision medicine. Consequently, the accurate identification of key driver genes for specific cancer types has become a central focus of bioinformatics research.
resultsWe present MODCAN, a novel semi-supervised algorithm based on multi-omics features and differential co-association networks. MODCAN facilitates the meaningful stratification of tumor samples into distinct subtypes, enabling a comprehensive exploration of multi-omics features that reflect the inherent heterogeneity of tumors. By constructing differential co-association networks, MODCAN reveals the unique genetic interactions characteristic of each subtype, thereby facilitating the complementary integration of information.
conclusionsWhen applied to ten cancer datasets from TCGA, MODCAN significantly outperforms both existing supervised and unsupervised learning algorithms, exhibiting superior performance in terms of precision, recall, and AUPR. Furthermore, MODCAN demonstrates substantial advantages in predicting potential tumor-specific driver genes. Notably, these genes not only exhibit strong specificity for their respective cancers, but also reveal tumor heterogeneity across distinct subtypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.